Using AI to Power Custom Treatments for Rare Diseases with Steven Ringel of Nome Therapeutics 11-10-25
Becker Private Equity & Business Podcast
November 10, 202510m 18s
Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Steven Ringel, CEO of the Kizuna Foundation and Nome Therapeutics, joins the podcast to discuss how his team is using artificial intelligence to make personalized medicine accessible for rare disease patients.